ProPhase Labs, Inc. (PRPH) stock
PRPHOTCPharmaceutical PreparationsFiscal year ends December 31
$0.01−0.00 (-6.16%)
Close on Oct 19, 2026Market cap $119.68KP/E –Yield –
ProPhase Labs profit margin
Profit margin (net margin) is net income as a percentage of revenue.
ProPhase Labs's profit margin for the twelve months ending Jun 30, 2026 was -583.9%. For fiscal 2025 it was -339.3%, against -788.2% the year before. The highest annual figure on record is 411.4% in fiscal 2017.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -339.3% | +448.9 |
| FY2024 | Dec 31, 2024 | -788.2% | −740.3 |
| FY2023 | Dec 31, 2023 | -48.0% | −63.0 |
| FY2022 | Dec 31, 2022 | 15.1% | +7.1 |
| FY2021 | Dec 31, 2021 | 7.9% | +22.6 |
| FY2020 | Dec 31, 2020 | -14.6% | +17.2 |
| FY2019 | Dec 31, 2019 | -31.9% | −18.6 |
| FY2018 | Dec 31, 2018 | -13.3% | −424.6 |
| FY2017 | Dec 31, 2017 | 411.4% | +479.5 |
| FY2016 | Dec 31, 2016 | -68.2% | +74.8 |
| FY2015 | Dec 31, 2015 | -143.0% | −107.5 |
| FY2014 | Dec 31, 2014 | -35.5% | −37.1 |
| FY2013 | Dec 31, 2013 | 1.6% | +6.5 |
| FY2012 | Dec 31, 2012 | -4.9% | +10.7 |
| FY2011 | Dec 31, 2011 | -15.5% | +8.6 |
| FY2010 | Dec 31, 2010 | -24.1% | −4.8 |
| FY2009 | Dec 31, 2009 | -19.4% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -301.8% | +56.8 |
| Q1 FY2026 | Mar 31, 2026 | -442.7% | −719.8 |
| Q4 FY2025 | Dec 31, 2025 | -943.6% | +1356.2 |
| Q3 FY2025 | Sep 30, 2025 | -774.5% | −309.3 |
| Q2 FY2025 | Jun 30, 2025 | -358.6% | +50.5 |
| Q1 FY2025 | Mar 31, 2025 | 277.1% | +543.1 |
| Q4 FY2024 | Dec 31, 2024 | -2299.8% | −2049.7 |
| Q3 FY2024 | Sep 30, 2024 | -465.2% | −403.7 |
| Q2 FY2024 | Jun 30, 2024 | -409.1% | −383.1 |
| Q1 FY2024 | Mar 31, 2024 | -265.9% | −268.8 |
| Q4 FY2023 | Dec 31, 2023 | -250.1% | −238.9 |
| Q3 FY2023 | Sep 30, 2023 | -61.5% | −65.5 |
| Q2 FY2023 | Jun 30, 2023 | -26.0% | −51.6 |
| Q1 FY2023 | Mar 31, 2023 | 2.8% | −23.4 |
| Q4 FY2022 | Dec 31, 2022 | -11.2% | −34.7 |
| Q3 FY2022 | Sep 30, 2022 | 4.0% | +45.9 |
| Q2 FY2022 | Jun 30, 2022 | 25.6% | +40.9 |
| Q1 FY2022 | Mar 31, 2022 | 26.3% | +19.4 |
| Q4 FY2021 | Dec 31, 2021 | 23.5% | +42.4 |
| Q3 FY2021 | Sep 30, 2021 | -41.9% | −31.2 |
| Q2 FY2021 | Jun 30, 2021 | -15.3% | −17.3 |
| Q1 FY2021 | Mar 31, 2021 | 6.9% | +49.8 |
| Q4 FY2020 | Dec 31, 2020 | -18.9% | −4.1 |
| Q3 FY2020 | Sep 30, 2020 | -10.6% | +4.8 |
| Q2 FY2020 | Jun 30, 2020 | 1.9% | +76.9 |
| Q1 FY2020 | Mar 31, 2020 | -42.8% | +0.9 |
| Q4 FY2019 | Dec 31, 2019 | -14.9% | −3.5 |
| Q3 FY2019 | Sep 30, 2019 | -15.5% | +27.9 |
| Q2 FY2019 | Jun 30, 2019 | -75.0% | −66.9 |
| Q1 FY2019 | Mar 31, 2019 | -43.7% | −45.0 |
| Q4 FY2018 | Dec 31, 2018 | -11.4% | −6.2 |
| Q3 FY2018 | Sep 30, 2018 | -43.3% | −17.8 |
| Q2 FY2018 | Jun 30, 2018 | -8.1% | +112.9 |
| Q1 FY2018 | Mar 31, 2018 | 1.3% | −5691.1 |
| Q4 FY2017 | Dec 31, 2017 | -5.2% | +69.4 |
| Q3 FY2017 | Sep 30, 2017 | -25.6% | −37.5 |
| Q2 FY2017 | Jun 30, 2017 | -121.0% | – |
| Q1 FY2017 | Mar 31, 2017 | 5692.3% | – |
| Q4 FY2016 | Dec 31, 2016 | -74.6% | – |
| Q3 FY2016 | Sep 30, 2016 | 11.9% | – |
See a number that looks wrong?